Efecto de la Nicotina en un Modelo de Activación Dopaminérgica en Timing: Hacia un Modelo en Esquizofrenia

Acta de Investigación Psicológica - Tập 6 - Trang 2262-2276 - 2016
Ivette González-Rivera1, Diana Berenice Paz-Trejo1, Hugo Sánchez-Castillo1
1Universidad Nacional Autónoma de México

Tài liệu tham khảo

Arroyo, 2011, Evaluation of cognitive impairment in schizophrenia model on a timing task Attaway, 1999, The effects of nicotine on learning and memory: a neuropsychological assessment in young and senescent Fischer 344 rats, Physiology and Behavior, 67, 421, 10.1016/S0031-9384(99)00081-5 Barr, 2008, Selfreported motivation to smoke in schizophrenia is related to antipsychotic drug treatment, Schizophrenia Research, 100, 252, 10.1016/j.schres.2007.11.027 Buhusi C.V., Perera D., Meck W.H. Memory for timing visual and auditory signals in albino and pigmented rats. J. Exp. Psychol. Anim. Behav. Process, 31,18-30. Carroll, 2008, Temporal Processing Dysfunction in Schizophrenia, Brain and Cognition, 67, 150, 10.1016/j.bandc.2007.12.005 Carroll, 2009, Timing dysfunctions in schizophrenia span from millisecond to several second durations, Brain & Cognition, 70, 181, 10.1016/j.bandc.2009.02.001 Dépatie, 2002, Nicotine and behavioral markers of risk for schizophrenia: adoubleblind, placebo-controlled, cross-over study, Neuropsychopharmacology, 27, 1056, 10.1016/S0893-133X(02)00372-X Dome, 2010, Smoking, nicotine and neuropsychiatric disorders, Neuroscience and Biobehavioral Reviews, 34, 295, 10.1016/j.neubiorev.2009.07.013 Jacobsen, 2004, Nicotine Effects on Brain Function and Functional Connectivity in Schizophrenia, Biological Psychiatry, 55, 850, 10.1016/j.biopsych.2003.12.023 Kumaria, 2005, Nicotine use in schizophrenia: The self medication hypotheses, Neuroscience and Biobehavioral Reviews, 29, 1021, 10.1016/j.neubiorev.2005.02.006 Larrison-Fauchera, 2004, Nicotine reduces antisaccade errors in task impaired schizophrenic subjects, Progress in Neuropsychopharmacology and Biological Psychiatry, 28, 505, 10.1016/j.pnpbp.2004.01.002 Lendvai, 2008, Nonsynaptic chemical transmission through nicotinic acetylcholine receptors, Physiol Rev., 88, 333, 10.1152/physrev.00040.2006 Levin, 1996, Acute and chronic nicotine effects on working memory in aged rats, Psychopharmacology, 123, 88, 10.1007/BF02246285 Levin, 1996, Nicotine-Haloperidol interactions and cognitive performance in schizophrenics, Neuropsychopharmacology, 15 Lohr, 1992, Smoking and schizophrenia, Schizophrenia Research, 8, 93, 10.1016/0920-9964(92)90024-Y Maricq, 1981, Metamphetamine and time estimation, Journal of Experimental Psychology: Animal Behavior Processes, 7, 18 McClure, 2011, A Drosophila model for fetal alcohol syndrome disorders: Role for the insulin pathway, Disease Models and Mechanisms, 4, 335, 10.1242/dmm.006411 Miyamoto, 2003, Recent Advances in the Neurobiology of Schizophrenia, Molecular interventions, 3, 1, 10.1124/mi.3.1.27 Mirza, 2001, Nicotine-induced enhancements in the five-choice serial reaction time task in rats are strain-dependent, Psychopharmacology, 154, 8, 10.1007/s002130000605 Moragrega, 2003, Spatial learning in male mice with different levels of aggressiveness: effects of housing conditions and nicotine administration, Behavioral Brain Research, 147, 1, 10.1016/S0166-4328(03)00112-8 Polanczyk, 2007, The worldwide prevalence of attention-deficit hyperactivity disorder: A systematic review and meta-regression analysis, Am J Psychiatry, 164, 942, 10.1176/ajp.2007.164.6.942 Popke, 2000, Effects of acute nicotine on several operant behaviors in rats, Pharmacology Biochemistry and Behavior, 65, 247, 10.1016/S0091-3057(99)00205-1 Sánchez-Castillo, 2013, Evaluación de la nicotina como estímulo aversivo, Acta de investigación psicológica, 3, 930, 10.1016/S2007-4719(13)70943-8 Smith, 2002, Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia, Neuropsychopharmacology, 27, 479, 10.1016/S0893-133X(02)00324-X Stahl, 2010 Ward, 2012, Timing as a window on cognition in schizophrenia, Neuropharmacology, 62, 1175, 10.1016/j.neuropharm.2011.04.014